Saturday, 14 December 2019

World News

  • Philips agrees to buy US firm Electrical Geodesics

    World |  News | 0 Comment | 28 Jun, 2017

    Netherlands-based Royal Philips has entered an agreement to purchase US-based Electrical Geodesics (EGI) for €32.9m. Philips is a Dutch technology company headquartered in Amsterdam&nb...Read more

  • Eli Lilly expands Biotechnology center

    World |  News | 0 Comment | 23 Jun, 2017

    Eli Lilly and Company has announced completion of a $90 million expansion of its Biotechnology Center in San Diego, California. Lilly's new space will help foster and accelerate the discove...Read more

  • $300M invested in biotech by Alphabet

    World |  News | 0 Comment | 22 Jun, 2017

    Google’s parent company Alphabet has invested $300 million in a new fund that will buy stakes in European biotech companies. Alphabet’s division Verily Life Sciences will be on...Read more

  • Intellia to win China patent for CRISPR

    World |  News | 0 Comment | 20 Jun, 2017

    Intellia Therapeutics has received notice from China’s State Intellectual Property Office (SIPO) that it will grant the company a broad patent covering CRISPR/Cas9 single-guide gene-e...Read more

  • Promising results for Ebola vaccine developed in Canada

    World |  News | 0 Comment | 19 Jun, 2017

    A phase 1 randomized controlled trial has found an Ebola virus disease (EVD) vaccine, developed in Canada, was well-tolerated with no safety concerns, and high antibodies were present in pa...Read more

  • Novartis and Verily promote biotech growth

    World |  News | 0 Comment | 16 Jun, 2017

    Novartis and Verily have helped Medicxi raise $300 million (€268 million) to invest in late-stage drug developers. The fund sees Medicxi move beyond its original focus on early-stage b...Read more

  • New management for type 2 diabetes

    World |  News | 0 Comment | 14 Jun, 2017

    Switzerland-based Ascensia Diabetes Care has entered a global technology partnership with French firm Voluntis to optimise insulin management for patients suffering from type 2 diabetes. V...Read more

  • OncoSec enters in a preclinical agreement

    World |  News | 0 Comment | 13 Jun, 2017

    OncoSec Medical Incorporated, a company developing DNA-based intra-tumoral cancer immunotherapies, has engaged in a preclinical agreement through the OncoSec Technology Access Program (TAP)...Read more

  • NIH funding for AIDS research

    World |  News | 0 Comment | 12 Jun, 2017

    The National Institutes of Health has awarded researchers at Albert Einstein College of Medicine, The Rockefeller University, The City University of New York Graduate School of Public Healt...Read more

  • Eli Lilly collaborates with Key Bioscience

    World |  News | 0 Comment | 09 Jun, 2017

    Eli Lilly will acquire worldwide rights from KeyBioscience to develop and commercialize its pipeline of dual amylin calcitonin receptor agonists (DACRAs) for type 2 diabetes and other metab...Read more

  • SciClone acquired for $605M

    World |  News | 0 Comment | 09 Jun, 2017

    SciClone Pharmaceuticals has agreed to be acquired for approximately $605 million by a consortium of Chinese investors, asserting that the deal would not only benefit shareholders but offer...Read more

  • A translational research collaboration

    World |  News | 0 Comment | 09 Jun, 2017

    The Scripps Research Institute (TSRI) and ShangPharma Innovation, Inc. (SPII) announced a strategic collaboration to accelerate the development of innovative drug candidates through a servi...Read more

  • Jackson Lab associates with Chinese groups

    World |  News | 0 Comment | 08 Jun, 2017

    The Jackson Laboratory has signed a collaborative clinical genomics research agreement with three groups in China. Specifically, the Jackson Lab has partnered with the Wenzhou Municipal Pe...Read more

  • Veloxis signs agreement with Italy’s Chiesi

    World |  News | 0 Comment | 08 Jun, 2017

    Veloxis Pharmaceuticals announced that its U.S. subsidiary, Veloxis Pharmaceuticals, Inc., has entered into an exclusive license, supply and distribution agreement with Chiesi Farmaceutici ...Read more

  • Immuno-oncology collaboration between F-Star and Merck KGaA

    World |  News | 0 Comment | 06 Jun, 2017

    Merck KGaA, Darmstadt, Germany, a leading science and technology company which operates its biopharmaceutical business as EMD Serono in the US and Canada, has announced a new strategic coll...Read more

  • Novartis teams up with IBM Watson Health

    World |  News | 0 Comment | 05 Jun, 2017

    The swiss drugmaker Novartis has agreed to work with IBM Watson Health to explore ways to use patient data and advanced analysis to glean insights on the likely outcomes of breast cancer tr...Read more

  • Cirina merges with GRAIL for cancer diagnostics

    World |  News | 0 Comment | 05 Jun, 2017

    GRAIL, Inc., a life sciences company whose mission is to detect cancer early when it can be cured has entered into a definitive agreement to combine with Cirina Ltd., a privately held compa...Read more

  • Cure-One partners with Guardant Health

    World |  News | 0 Comment | 05 Jun, 2017

    Cure-One, a non-profit organization dedicated to advancing precision medicine, announced the participation of Guardant Health, the leader in comprehensive liquid biopsy testing, as a corner...Read more